Geode Capital Management
KYNB

Geode Capital Management’s Kyntra Bio KYNB Stock Holding History

Geode Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Sell
43,219
-2,779
-6% -$19.5K ﹤0.01% 3752
2026
Q1 		$312K Buy
45,998
+2,294
+5% +$18K ﹤0.01% 3761
2025
Q4 		$384K Buy
43,704
+22
+0.1% +$215 ﹤0.01% 3693
2025
Q3 		$535K Sell
43,682
-354
-0.8% -$3.33K ﹤0.01% 3591
2025
Q2 		$233K Buy
44,036
+856
+2% +$6.24K ﹤0.01% 3823
2025
Q1 		$335K Buy
43,180
+846
+2% +$10.1K ﹤0.01% 3683
2024
Q4 		$561K Sell
42,334
-1,007
-2% -$9.36K ﹤0.01% 3563
2024
Q3 		$433K Buy
43,341
+1,316
+3% +$19.9K ﹤0.01% 3643
2024
Q2 		$938K Sell
42,025
-40,962
-49% -$1.27M ﹤0.01% 3331
2024
Q1 		$4.88M Buy
82,987
+2,256
+3% +$97.2K ﹤0.01% 2719
2023
Q4 		$1.79M Buy
80,731
+5,333
+7% +$80.4K ﹤0.01% 3144
2023
Q3 		$1.63M Buy
75,398
+584
+0.8% +$22.9K ﹤0.01% 3144
2023
Q2 		$5.05M Buy
74,814
+5,712
+8% +$2.36M ﹤0.01% 2672
2023
Q1 		$32.2M Buy
69,102
+2,818
+4% +$1.49M ﹤0.01% 1483
2022
Q4 		$26.5M Buy
66,284
+2,083
+3% +$798K ﹤0.01% 1590
2022
Q3 		$20.9M Buy
64,201
+1,705
+3% +$549K ﹤0.01% 1702
2022
Q2 		$16.5M Sell
62,496
-927
-1% -$237K ﹤0.01% 1890
2022
Q1 		$19.1M Sell
63,423
-1,601
-2% -$558K ﹤0.01% 1934
2021
Q4 		$22.9M Buy
65,024
+14,940
+30% +$4.65M ﹤0.01% 1859
2021
Q3 		$12.8M Sell
50,084
-10,058
-17% -$3.56M ﹤0.01% 2284
2021
Q2 		$40M Buy
60,142
+2,956
+5% +$1.7M 0.01% 1498
2021
Q1 		$49.6M Buy
57,186
+3,643
+7% +$3.88M 0.01% 1239
2020
Q4 		$49.6M Buy
53,543
+2,850
+6% +$3M 0.01% 1100
2020
Q3 		$52.1M Buy
50,693
+4
+0% +$4.3K 0.01% 890
2020
Q2 		$51.4M Buy
50,689
+2,804
+6% +$2.6M 0.01% 881
2020
Q1 		$41.6M Buy
47,885
+3,224
+7% +$3.2M 0.01% 853
2019
Q4 		$47.9M Buy
44,661
+1,914
+4% +$1.95M 0.01% 962
2019
Q3 		$39.5M Buy
42,747
+1,705
+4% +$1.87M 0.01% 1016
2019
Q2 		$46.4M Buy
41,042
+2,782
+7% +$3.04M 0.01% 909
2019
Q1 		$52M Buy
38,260
+3,056
+9% +$4.14M 0.01% 818
2018
Q4 		$40.7M Buy
35,204
+2,013
+6% +$2.26M 0.01% 837
2018
Q3 		$50.4M Buy
33,191
+773
+2% +$1.19M 0.01% 798
2018
Q2 		$50.7M Buy
32,418
+3,683
+13% +$4.8M 0.02% 760
2018
Q1 		$33.2M Sell
28,735
-220
-0.8% -$290K 0.01% 939
2017
Q4 		$34.3M Buy
28,955
+93
+0.3% +$117K 0.01% 912
2017
Q3 		$38.8M Buy
28,862
+6,907
+31% +$7.28M 0.01% 797
2017
Q2 		$17.7M Buy
21,955
+3,445
+19% +$2.4M 0.01% 1274
2017
Q1 		$11.4M Buy
18,510
+2,311
+14% +$1.41M ﹤0.01% 1525
2016
Q4 		$8.67M Sell
16,199
-372
-2% -$186K ﹤0.01% 1683
2016
Q3 		$8.57M Sell
16,571
-321
-2% -$151K ﹤0.01% 1591
2016
Q2 		$6.93M Buy
16,892
+1,858
+12% +$851K ﹤0.01% 1683
2016
Q1 		$8M Sell
15,034
-66
-0.4% -$32.9K ﹤0.01% 1544
2015
Q4 		$11.5M Buy
15,100
+1,586
+12% +$1.05M 0.01% 1271
2015
Q3 		$7.41M Buy
13,514
+9,062
+204% +$5.49M ﹤0.01% 1561
2015
Q2 		$2.62M Buy
4,452
+1,576
+55% +$917K ﹤0.01% 2323
2015
Q1 		$2.26M Buy
2,876
+451
+19% +$350K ﹤0.01% 2362
2014
Q4 		$1.66M Buy
+2,425
New +$1.56M ﹤0.01% 2540

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management's KYNB Position: Q2 2026 in Review

Geode Capital Management reduced its Kyntra Bio (KYNB) stake by 6% in Q2 2026, selling an estimated $19.5K and leaving 43,219 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #3752.

Geode Capital Management first reported a position in KYNB in Q4 2014 and has held it in 47 quarters since. The position peaked at $52.1M in Q3 2020. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.

  • Geode Capital Management held 43,219 shares of Kyntra Bio worth $326K as of Q2 2026.
  • Geode Capital Management sold 2,779 Kyntra Bio shares in Q2 2026, an estimated $19.5K.
  • Kyntra Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3752 holding.
  • Geode Capital Management first reported a position in Kyntra Bio in Q4 2014 and has held it in 47 quarters since.
  • Geode Capital Management's Kyntra Bio position peaked at $52.1M in Q3 2020.
  • 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.